CIK 0001604464 · Non-accelerated filer<br>Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460920988
- Phone
- 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K Event Material agreement
- 4 Open-market sale Chief Financial Officer sold 1,469 shares at $19.77 ($29,048)
- 4 Open-market sale Chief Operations Officer sold 1,648 shares at $19.77 ($32,588)
- 4 Open-market sale President and CEO sold 4,716 shares at $19.77 ($93,254)
- 4 Open-market sale Chief Operations Officer sold 7,500 shares at an average $18.49 ($138,688)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale President and CEO sold 4,807 shares at $12.09 ($58,117)
- 4 Open-market sale Chief Financial Officer sold 1,496 shares at $12.09 ($18,087)
- 4 Open-market sale Chief Operations Officer sold 1,678 shares at $12.09 ($20,287)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale President and CEO sold 12,135 shares at $12.92 ($156,784)
- 8-K Event Shareholder vote results
- 4 Grant or award Director acquired 8,000 shares (grant or award)
- 4 Grant or award Director acquired 8,000 shares (grant or award)
- 4 Grant or award Director acquired 8,000 shares (grant or award)
Page 24 of 57 · 1,133 filings